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INTRODUCTION: Thyroglossal duct cysts (TDC) are commonmidline neck swellings resulting fromembry-
ological remnants of the thyroglossal duct. They often contain ectopic thyroid tissue and malignant
transformation has been reported, most commonly to papillary thyroid carcinoma. Mucoepidermoid
carcinoma (MEC) usually occurs in the salivary glands and only rarely in the thyroid. This is the ﬁrst case
of a MEC occurring within a thyroglossal duct remnant.
PRESENTATIONOF A CASE:A73 year old lady presentedwith a thyroglossal duct cyst. She declined surgical
excision, as she was adamant she wanted to avoid surgery. The neck mass rapidly enlarged at two years
following initial diagnosis. Fine needle aspiration cytology was suspicious for carcinoma. She underwent
total thyroidectomy and selective central compartment neck dissection with adjuvant radiotherapy. She
remains alive and well two years post treatment.
DISCUSSION: Mucoepidermoid carcinoma is the most common malignant neoplasm of salivary glands,
although it has rarely been reported in diverse locations including the thyroid, lung and pancreas. To
the best of our knowledge, this is the ﬁrst reported case of mucoepidermoid carcinoma arising from a
thyroglossal duct remnant.
CONCLUSION: This case adds weight to the literature favouring surgical excision of thyroglossal duct
remnants due to the risk of malignant transformation.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Thyroglossal duct cysts (TDC) are common midline neck
swellings. Usually presenting in childhood, they can be also be
found in up to 7% of the adult population [1]. They develop in rests
of epithelium sequestered in migration during the formation and
disappearance of the thyroglossal duct. Islands of epithelium may
persist throughout life as ectopic thyroid tissue but often undergo
cystic degeneration to form thyroglossal duct cysts [2]. The com-
monest site for such cysts is around the body of the hyoid bone.
Malignant transformation occurs in 1% of TDC and is usually of the
papillary carcinoma type [3]. There are two theories for how this
occurs, either the tumour arises from themalignant transformation
of ectopic thyroid tissue retainedwithin the duct, or arises de-novo
from cells lining the duct [4]. Mucoepidermoid carcinomas are best
characterised in salivary glands, rarely occurring in other glandu-
lar tissue including lung, lacrimal glands, and thyroid. Of the 40
cases of thyroid MEC in the literature to date the majority are low
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grade variants, for example, thyroid sclerosing mucoepidermoid
carcinomawith stromal eosinophilia. High-grademucoepidermoid
carcinomas are found even less frequently in the thyroid gland. This
is the ﬁrst reported case of amucoepidermoid carcinoma occurring
within a thyroglossal duct cyst.
2. Case report
A 73-year-old lady of Bangladeshi origin initially presented to
the endocrine surgeons with a two-year history of a gradually
enlarging midline neck lump, which moved on tongue protrusion.
There was no lymphadenopathy or abnormality within the thyroid
gland itself, and thyroid function tests were normal. Additionally
there were no suspicious clinical features; she was a non-smoker,
with no history of alcohol consumption. Clinically, the neck lump
was felt to be an uncomplicated thyroglossal duct cyst. Ultrasound
scan showed a cystic lesion of 27mm in maximal dimension, supe-
rior to and separate from the thyroid gland (Fig. 1), whilst ﬁne
needle aspiration cytology (FNAC), revealed features consistent
with a thyroglossal duct cyst.
Surgical excision was recommended but the patient declined.
She agreed to regular follow-up. The neck mass gradually enlarged
over the course of 12 months, but the patient still declined surgery.
Two years following her initial presentation, the neck mass rapidly
http://dx.doi.org/10.1016/j.ijscr.2015.04.028
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Ultrasound images from initial clinic presentation.
A: Midline view showing central cystic lesion.
B: Doppler showing no evidence of increased vascularity.
C: Right lobe of the thyroid showing evidence of colloid cyst, otherwise normal appearances.
D: Left lobe of thyroid showing normal appearances of the gland.
Fig. 2. CT scan of the neck (sagittal view).
A: Sagittal (non-contrast) view of the neck showing anterior midline neck mass
extending from the suprasternal notch to the hyoid bone.
expanded in size and the patient was assessed urgently in the head
and neck cancer clinic. At this time, a large hard mass with maxi-
mal dimension of 70mm was palpable in the region of the thyroid
gland. Clinically, therewasno stridor or cervical lymphadenopathy.
FNAC was highly suspicious for malignancy. A computed tomogra-
phy (CT) scan of the neck conﬁrmed the presence of a large anterior
midline neck mass measuring, 50mm×70mm×66mm, extend-
ing from the level of the thyroid to the hyoid bone (Fig. 2). CT scans
of chest, abdomen and pelvis, did not show any evidence of distant
metastases.
T2 weighted MRI axial (A) and coronal STIR (B) images
demonstrating a 68mm×47mm×93mm mixed T2 isoin-
tense/hyperintense infrahyoid lesion. It indents the superior
thyroid gland and displaces the larynx and trachea posteriorly.
A T1/T2 weighted magnetic resonance imaging (MRI) of the
face and neck with STIR and diffusion imaging was performed to
evaluate the lesion further (Fig. 3). The mass measured 68mm
(long axial dimension)×47mm (short axial dimension)×93mm
(cranio–caudal), extending inferiorly to the suprasternal notch, and
superiorly to the level of the hyoid bone. A small volume of thyroid
tissue was noted postero-inferior to the mass, and some slightly
enlarged level IV lymph nodes (up to 13mm).
Following discussion at the head and neck cancer multidisci-
plinary meeting, she underwent total thyroidectomy and level VI
neck dissection, duringwhich a partially necrotic tumourmasswas
excised (Fig. 4). Histological examination revealed a high-grade
mucoepidermoid carcinoma above the gland consistentwith origin
in a thyroglossal duct remnant (Fig. 5). Six central compartment
neck nodes were retrieved, with no evidence of metastasis. The
carcinoma was investigated for MECT1/MAML2 (CRTC1/MAML2)
translocation typical of mucoepidermoid carcinoma by ﬂuores-
cence in-situ hybridisation using a MAML2 dual colour break apart
probe (Zytovision GmBH, Bremerhaven, Germany). The carcinoma
cells were negative for the translocation but showed a slightly
increased copy number 2–4 throughout.
Apart fromareturn to theatre for evacuationofneckhaematoma
at one-week post surgery, she had an uneventful post-operative
recovery. She underwent adjuvant radiotherapy (60Gy in 30
fractions) in view of close surgical margins. She experienced
radiotherapy related side effects including mucositis, which were
managed conservatively with analgesia and steroids and is alive
two years following completion of oncological treatment.
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Fig. 3. T2 weighted MRI axial (A) and coronal STIR (B) images demonstrating a 68mm×47mm×93mm mixed T2 isointense/hyperintense infrahyoid lesion. It indents the
superior thyroid gland and displaces the larynx and trachea posteriorly.
To the best of our knowledge, this is the ﬁrst reported case
of MEC arising within an existing thyroglossal duct remnant. We
present a reviewof the literature onmucoepidermoid carcinoma of
the thyroid and recommend that surgical excision of these lesions
should be performed due to the risk of malignant transformation.
3. Discussion
MEC are one of the most common malignant neoplasms of sali-
vary glands in adults, but also arise in sites as diverse as the lung,
breast, pancreas, oesophagus, lacrimal ducts and thyroid [5–10],
where a high index of suspicion is needed for accurate diagnosis.
In the medical literature to date there are only 40 reported cases of
thyroid MEC, and no previous cases of mucoepidermoid carcinoma
arising in a thyroglossal duct cyst [9,12–13].
MECwasﬁrst described by Stewart in 1945 [11]. Onset is usually
in the 5th decade of life, and it usually presentswith aﬁxedpainless
enlarging swelling [1]. Women are more commonly affected than
men [2]. Typical histopathological features include the presence of
epidermoid, mucinous and clear cells (see Fig. 5).
Mucoepidermoid carcinoma is consistently associated with
a t(11;19)(q21;p13) translocation that produces a fusion pro-
tein combining the CREB-regulated transcription coactivator 1
(CRTC1/MECT1) with Notch coactivator mastermind-like gene 2
(MAML2) that constitutively activates the Notch signalling path-
way important in development and oncogenesis [14,16,17]. This
change was thought to be a causative oncogenic event, though
it has since also been found in a minority of Warthin’s tumours
and hidradenocarcinomas [15]. In mucoepidermoid carcinomas
of salivary glands the translocation is associated with low and
intermediate grade carcinomas and a lower risk of recurrence,
Fig. 4. Macroscopic histopathology.
A: Macroscopic specimen from total thyroidectomy: a single spherical mass 89mm×80mm×55mm without identiﬁable left or right lobes, or obvious thyroid capsule.
B: Cut surface demonstrates well circumscribed, partly necrotic tumour mass
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Fig. 5. Microscopic histopathology demonstrating mucoepidermoid tumour.
A: High power image showing epidermoid, clear and mucinous cells.
B: Cytokeratin 5/6 immunohistochemistry conﬁrms epidermoid differentiation (brown stain).
C: B/PAS stain reveals mucin secretion (blue).
metastasis and death than those without [16]. However, approx-
imately only a quarter of high grade mucoepidermoid carcinomas
contain the translocation, and those that are positive are thought
to arise by high grade transformation from low grade carcinomas
[17]. Our presented case did not contain the translocation, suggest-
ing that, despite itsmucoepidermoid differentiation, it did not arise
through translocation as most low grade salivary gland carcinomas
do.
There is paucity of knowledge on thyroid MEC, but three cases
have been shown to be positive for the t(11;19)(q21;p13) translo-
cation [16–19]. As the majority of thyroid MEC are low grade, the
ﬁnding that this unusual high grade tumour lacks the translocation
is interesting and suggests that, as in salivary gland neoplasms, the
high grade carcinomas are a biologically and molecularly different
group.
There are two main theories for the histogenesis of thyroid
MEC; that it develops from solid cell nests (SCN) or thyroid follicu-
lar epithelial cells [10]. SCN share many histopathological features
with MEC, including ductal structures lined by ciliated epithelium,
and multipotent cells. These multipotent cells have been linked
to several thyroid cancers, including papillary and MEC. Alterna-
tively, it is thought that papillary carcinoma (the most common
malignancy found in thyroglossal duct remnants), may undergo
squamous and mucinous metaplasia resulting in MEC [21,22,13].
Prichard et al. report three cases where de-differentiation appears
to have occurred from other thyroid neoplasms [13]. In addition,
thyroid speciﬁc mRNAs including TTF-1 and PAX-8, which are
exclusively found together in thyroid follicular cells were both
detected in a metastatic axillary lymph node of MEC [21]. It is not
clear, whether MEC in a thyroglossal duct remnant has arisen via
the same means as a thyroid MEC, or via another as yet unspeciﬁed
mechanism.
The sudden onset enlargement of our patient’s presumed thy-
roglossal duct cyst and suspicion of nodal disease on pre-operative
imaging lead to the decision for aggressive surgical management
with total thyroidectomy and selective level VI neck dissection
rather than the more conservative Sistrunk procedure. The avail-
able literature supports the use of adjuvant radiotherapy in cases
of high grade tumours, which generally carry a poor prognosis
[23–25]. In addition, the posterior extension of the tumour to
the trachea, necessitated incomplete resection margins that would
have potentially dictated a poorer outcome without additional
treatment. Pritchard et al. [13] support the use of radioiodine
ablation due to the possible origins of these tumours having
de-differentiated from other thyroid neoplasms. Thankfully, our
patient is alive at two years following the completion of oncological
treatment.
4. Conclusion
In conclusion, we report, to the best of our knowledge, the ﬁrst
caseofmucoepidermoidcarcinomaarising froma thyroglossal duct
remnant. Whilst the majority of thyroglossal duct carcinomas are
of papillary type, a high index of suspicion must be kept in case of
more aggressive carcinomas. This case highlights the importance
of removal of thyroglossal duct cysts at an early stage, and lends
weight to the argument for a more radical surgical approach, and
adjuvant treatment particularly for large carcinomas, orwhen clear








Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy
of the written consent is available for review by the Editor-in-Chief
of this journal on request.
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